Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05877118 · ClinicalTrials.gov registry record · NA
Improving Availability of Intranasal Naloxone
A NA study of Opioid Overdose, sponsored by Hartford Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 2
- Study locations
NCT05877118: Recruiting NA study of Opioid Overdose, sponsored by Hartford Hospital.
NCT05877118 is a NA study of Opioid Overdose that is actively recruiting participants, run by Hartford Hospital. The registered enrollment target is 84 participants, below the 4,232-participant average among 8 other Opioid Overdose trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05877118, a NA study of Opioid Overdose, is actively recruiting participants, sponsored by Hartford Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 2
- Study locations
Study Summary
While there is a lifesaving medication called naloxone that can reverse the deadly effects of opioid overdose, patients often fail to fill the prescription at the pharmacy when it is prescribed. This is particularly concerning and true in those at the highest risk of death-those who end up in the emergency department for opioid overdose. The goal of this study is to compare the impact of different overdose education on naloxone prescription fill rates in opioid users being discharged from our hospital emergency department. You will receive either (a) written education about naloxone through their MyChart account, or (b) a concise one-page handout and 4-minute video clip reviewed with the participant and a support individual (family/friend) prior to discharge.
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Overdose Education (EOE)
- BEHAVIORAL Standard education
Study Locations (2)
Connecticut
- Hartford Hospital Emergency Department - Hartford
- Olin Neuropsychiatry Research Center - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT05877118 shows while recruiting
NCT05877118 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 4,232-participant average among 8 other Opioid Overdose trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Opioid Overdose appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Overdose Education (EOE) is the first listed.
NCT05877118 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05877118 about?
NCT05877118 is a clinical study titled "Improving Availability of Intranasal Naloxone". While there is a lifesaving medication called naloxone that can reverse the deadly effects of opioid overdose, patients often fail to fill the prescription at the pharmacy when it is prescribed. This is particularly concerning and true in those at the highest risk of death-those who end up in the em...
What is the current status of trial NCT05877118?
This trial is currently recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2024-03-01. Estimated completion is 2025-12-31.
What conditions does trial NCT05877118 study?
This clinical trial studies the following conditions: Opioid Overdose.
What interventions are being tested in trial NCT05877118?
The interventions under investigation include: Enhanced Overdose Education (EOE) (BEHAVIORAL), Standard education (BEHAVIORAL).
Who is sponsoring clinical trial NCT05877118?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05877118 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Overdose
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05877118's enrollment target sits among peer trials
84 7th of 8 higher than 2 of 8 other Opioid Overdose trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Overdose trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
Opioid Rapid Response System: Naloxone Training in Communities
COMPLETED · NA
-
A Bundled Intervention
RECRUITING · Phase 1
-
Quantitative Xylazine Measurement in ED
RECRUITING
-
Vending Machine Naloxone Distribution for Your Community (VENDY)
RECRUITING · Phase 4
-
Young Houston Emergency Opioid Engagement System
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI